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ABSTRACT The early detection of cancer cells and their visualisation before and after surgery 
are essential for successful pre- and post-operative disease management. Although fluorescence 
imaging is a sensitive and versatile tool that is finding increasing use in clinical applications, there 
is a lack of tumour-targeting fluorophores. We report here a family of fluorescent Schiff base 
organotin dyes (1: Et2N-L-SnPh2, 2: Et2N-L-SnBu2, 3: MeO-L-SnPh2, 4: MeO-L-SnBu2, 5: HO-L-
SnPh2, and 6: HO-L-SnBu2, where L = 2-hydroxybenzylidene-4-hydroxybenzhydrazine). In 
addition to one-photon-excited fluorescence, efficient two-photon excitation was demonstrated in 
compounds 1-4. Two of the compounds (5 and 6), both with hydroxyl substituents, were capable 
of selective accumulation in HeLa cells, allowing differentiation from normal cells (periodontal 
ligament cells). Compounds 1 and 3 showed excellent cancer cell staining (HeLa) using two-
photon bioimaging which is promising for biomedicine applications. 
Introduction 
The use of contrast markers for the detection of cancer cells is an attractive approach to improve 
the management of this disease.[1] The main goal in this field is to develop tumor-imaging agents 
that can be selective to target cells.[2] In cancer diagnosis, the early identification of cell 
abnormalities significantly reduces the mortality rate. Fluorescence imaging has proved to be an 
important tool with clinical applications, due to advantages such as high sensitivity and 
versatility.[3-6] Resection surgery is the gold standard treatment for most solid tumors, and the 
fluorescent probes have been used to enhance structural differences between normal and cancer 
cells. The presence of remaining transformed cells in the tumor margins after surgical treatment is 
usually considered one of the strongest predictors of tumor recurrence and survival.[7] In recent 
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decades, a range of fluorescent materials have been proposed as imaging probes for cancer 
diagnosis, including nanoparticles,[8,9] quantum dots,[10] and organometallic molecules.[11,12]  
An important difference between many tumors and normal tissues is the nutritional and metabolic 
environment. The production of lactic acid under anaerobic conditions and the hydrolysis of ATP 
in an energy-deficient environment contribute to the acidic microenvironment which has been 
found in several tumor types.[13] In this context, pH differences have been the basis of cancer 
treatments and probes for diagnosis.[14] The modulation of the fluorescent properties can also be 
influenced by other external factors such as viscosity and temperature.[15-17] Recently, biologically-
active compounds derived from Schiff base molecules have shown promise as fluorescent 
reporters.[18,19] These molecules possess the azomethine fragment (-N=CH), which is the key to 
the design of new drugs with anti-convulsant, anti-depressant, analgesic, anti-inflammatory, and 
anti-malarial activity. The generation of Schiff base derivatives with high thermal stability to air 
and moisture as well as diverse biological activity have been reported.[20,21] The structural diversity 
of the organotin compounds derived from Schiff bases, and their applications, have been a major 
impetus for the investigation of these molecules.[22,23] Recently, we reported luminescent organotin 
derivatives and their application in bioimaging studies.[24,25] Here we show that a family of 
organotin compounds have attractive fluorescent properties, via one-photon (1P) and two-photon 
(2P) excitation, and that they can selectively penetrate and stain cancer cells and be differentiated 
from normal cells. 
Results and Discussion  
Synthesis and characterization. The one-pot reaction of a 5-substituted salicylaldehyde 
derivative, 4-hydroxy-benzoylhydrazine and the corresponding diorganotin oxide afforded the 
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pentacoordinated organotin derivatives (1-6) in yields from 55 to 95% as yellow solids (Scheme 
1). The 119Sn NMR spectra of dibutyltin derivatives (2, 4, and 6) show a single resonance within 
the range of –194.4 to –198.6 ppm, while in the diphenyl tin complexes (1, 3, and 5) this is shifted 
to  –331.3 to –336.5 ppm. The 13C NMR spectra (CD3OD) for all of the organotin compounds (1-
6) exhibited the δ of imine carbons (C-7) in the range of 160.24 to 161.55 ppm (Table 1). The 
signals assigned to the azomethine protons (H-7) in the 1H NMR spectra appear in the range of 
8.45-8.66 ppm and the 3J(1H-N-119Sn) from 40.9 to 57.6 Hz, confirming the presence of N→Sn 
coordination bonds, which is in agreement with previous reports.[26] Elemental analyses of the 
compounds were difficult to obtain but the high-resolution mass spectra were in good agreement. 
 
Scheme 1. Synthesis of organotin compounds 1-6. 




   C-7         C-a/Ci        C-1       C-8 
119Sn 
 
1 8.48 [57.6] 160.51 140.94 170.08 168.56 -331.35 
2 8.45 [46.8] 160.24 22.47 169.49 169.34 -194.41 
3 8.66 [54.7] 161.55 140.92 170.75 170.07 -336.54 
4 8.62 [40.9] 161.26 22.87 170.31 170.27 -198.64 
5 8.63 [54.8] 161.46 140.68 170.75 169.58 -335.50 
 5 
6 8.57 [43.6] 161.38 22.75 170.17 170.11 -197.88 
 
The single crystal X-ray diffraction structure of 5 is represented by the thermal ellipsoid plots in 
Figure 1 (see Table S1 for details). The crystal structure shows a planar skeleton array with a 
pentacoordinated tin atom and with N-Sn coordination bond length of 2.1459(18) Å. The C-C bond 
lengths of the aromatic systems correspond to the data previously reported for similar molecules.[27] 
The tin atom adopts a distorted trigonal bipyramid geometry. The X-ray diffraction structure of 4 
shows a similar coordination number in the tin atom as well as the planar skeleton array. 
Additionally, compound 4 shows intermolecular p-stacking (Figures S1 and S2). 
 
 
Figure 1. Crystal X-ray structure of compound 5. Selected bond distances: Sn-O1 2.0697(15), 
Sn-O2 2.1342(15), Sn-N1 2.1459(18), Sn-C16 2.107(2), Sn-C15 2.119(2), and N1-C7 1.293(3) Å. 
Selected angles: O1-Sn-O2 156.41(7), C15-Sn-C16 125.32(9), N1-Sn-O2 72.88(6), N1-Sn-O1 
83.60°(6) 
 
Photophysical characterization. The 1P photophysical properties of the six compounds were 
studied in ethanol, DMSO, and DMF solutions. Steady-state absorption and emission for a 
particular sample are similar in each solvent (Figures S3-S8). In general, all of the compounds 
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exhibit a main absorption peak in the visible, with maximum wavelength ranging between 398 and 
446 nm, which is attributed to p-p* transitions (Figure 2a and Figures S3-5). The position of the 
maximum absorption band depends on the Schiff base substituent; those with the diethylamine 
group (1 and 2) are red shifted when compared to the other compounds, which have methoxy and 
hydroxy groups. Compounds 1 and 2 are noticeably red-shifted and have a structured absorption 




Figure 2. Electronic absorption spectra (a) and 1P emission spectra (b) of compounds 1-6 in 
methanol. See SI for spectra in ethanol, DMF, and DMSO. 
 
The emission is most intense between 450-500 nm (Figure 2b and Figures S6-8). 1 and 2 are 
distinct from the other four compounds, with a red-shifted structured emission, with separation in 
peaks of ~1100 cm–1, similar to the peak separation in the absorption spectra. The absorption and 
emission spectra for compounds 3-6 are qualitatively similar to 1 and 2, but display a peak and 
shoulder rather than two distinct peaks. We attribute the peaks in the absorption and emission 
spectra of 1-6 to vibronic transitions.  The fluorescence quantum yields for 1-6 range from 13-34% 
(Table 2 and Tables S2-4). They are relatively independent of the solvent and are highest for 3 and 
4. We attribute the longest wavelength absorption and emission peaks to p-p* transitions, which 
agrees with the observed extinction coefficients. The quantum yields compare favourably with 
similar pentacoordinated tin compounds derived from Schiff bases.[29] 
The 1P fluorescence lifetimes were measured using time-correlated single-photon counting 
(TCSPC). Compounds 1-4 followed monoexponential kinetics in all solvents (Table 2 and Tables 
S2-4). Compound 6 displayed monoexponential kinetics in methanol, ethanol, and DMF but 
biexponential kinetics in DMSO, while 5 displayed biexponential kinetics in DMF and DMSO. 
The general trend in each solvent was that 1-4 had lifetimes that were similar to each other (ranging 
from 1.7- 2.0 ns) but longer than 5 and 6 (1.5-1.8 ns). For 5 in DMF and DMSO, the longer lifetime 
component is similar (1.7 ns) to the lifetime observed in methanol and ethanol and accounts for 
60% of the population; the shorter component is 0.19 ns in DMF and 0.28 ns in DMSO. 
Interestingly, although the fit to a single exponential decay in DMSO for 5 is very poor (c2 ~ 24), 
the incremental addition of water results in a concomitant increase in the population of the longer 
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lifetime component, so that after only 2% v/v water addition the lifetime is single exponential with 
a lifetime of 1.69 ns (c2 = 1.01).  For 6 in DMSO, the major component (84%) is similar to the 
lifetime in the other solvents (1.7 ns), while the short component is 0.62 ns. As for 5, the data 
cannot be fitted to a single exponential decay in pure DMSO (c2 ~ 3), but an addition of 10% water 
results in a monoexponential decay with a lifetime of 1.67 ns (c2 = 1.03). Similar behaviour is 
observed for 5 in DMF, where the lifetime is essentially monoexponential (c2 = 1.19) with a 
lifetime of 1.59 ns after addition of 10% water. The lifetimes of 5 and 6 in DMSO/DMF in the 
presence of water are similar to those measured in methanol and ethanol. Therefore, we attribute 
them to interactions between the hydroxyl on R’ (Scheme 1) and the polar protic solvents. 
 
Table 2. Photophysical parameters for compounds 1-6 in methanol.[a] 
Comp. lmax[b] [nm] ε 
[c] lem [nm][d] F [%][e] t [ns][f] c2[g] s2 [h] [GM] 
1 421, 441 3.51 462, 488 16 1.94 0.98 50 
2 421, 440 3.67 460, 488 16 1.86 0.97 48 
3 328, 400 2.25 448, 470 27 1.67 1.04 3.5 
4 327, 401 2.39 450, 472 27 1.75 1.00 5.5 
5 330, 400 2.06 450, 468 22 1.46 1.03 - 
6 329, 401 2.89 448, 470 22 1.53 1.02 - 
[a] See SI for experimental details and for data in ethanol, DMSO and DMF. [b] 
Absorption maxima. [c] Extinction coefficient at longest wavelength maxima in 
units of 104 M–1cm–1.[d] Emission maximum. [e] Emission quantum yield 
(excited at 366 nm). [f] Fluorescence lifetime (excited at 430 nm). [g] single-
exponential decay fit parameter. [h] Two-photon cross section. The accuracy of the 
measurements was estimated to be ± 20%. 
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In addition to studying the 1P fluorescence properties, we investigated the potential for 2P 
activation of fluorescence. 2P microscopy could offer advantages such as 3D control of excitation, 
deep tissue penetration, and reduced photobleaching.[30] We studied compounds 1-4 in methanol 
and found that they could all undergo 2P excitation. The 2P emission spectra were the same as 
those measured via 1P excitation (Figure 3a). The log-log plots of emission intensity versus power 
confirm a 2P process (Figure 3b). The 2P cross sections (Table 1) are ~50 GM (GM = 10–50 cm4 s 
photon–1) for 1 and 2 and ~ 5 GM for 3 and 4, following excitation at 800 nm, which is close to 
double the 1P absorption maxima (Figure 2). These 2P cross sections are consistent with those of 
other organotin complexes.[31,32] It is noteworthy that when organotin compounds are linked to the 




Figure 3. 2P excitation of organotin complexes. (a) Emission spectra of 1-4 in methanol (excited 
at 800 nm with 10 nm FWHM). (b) Power dependence of 1 in methanol. The slope is 2.05(1) 
indicating a 2P process. 
Fluorescence bioimaging. We next investigated the biological interaction of organotin 
compounds (see SI for experimental details). 1P fluorescence microscopy was used to performed 
experiments on periodontal ligament cells (PDLCs) and HeLa cells. After isolation and primary 
culture, PDLCs showed a typical fibroblastic-elongated morphology and tended to align 
themselves in parallel lines. A polygonal-shaped cell appearance was observed in HeLa cells after 
incubation. Some morphological differences in both cell types were detected, such as length, 
shape, and size (Figure 4).   
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Figure 4. Biological activity of organotin compounds 1-6 was analyzed by 1P fluorescence 
microscopy on PDLCs and HeLa cells. Representative images from cells incubated with the 
organotin dyes are shown. Emission was detected in both cell types, however, for the compounds 
1, 2, and 3, a significant difference in the fluorescence intensity was not detected. The HeLa cells 
treated with 5 and 6, showed a strong-bright emission intensity located in the nucleoli and 
ribosomes. All molecules were excited in the UV region (360-370 nm) and detected in the range 
420-460 nm. Original magnification 20x, scale bar =50 μm. 
After exposure to organotin compounds for 10 min, the cytoplasmic content of PDLCs and HeLa 
cells exhibited fluorescence (detected from 420-460 nm) after excitation in the region 360-370 nm, 
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indicating that all six organotin complexes are capable of binding to mammalian cells. A moderate 
fluorescence was observed in cells treated with the dyes 1, 2, 3, and 4; however, in the HeLa cells 
stained with the organotin compounds 5 and 6, a stronger fluorescence was observed, which was 
more localized in the cytoplasm, nucleoli and ribosomes in comparison with the PDLCs (Figure 
4). It is known that the morphological and functional modifications in the nucleolus, widely 
observed in tumor cells, are accompanied by a significant increase in the synthesis of proteins 
related to cell cycle regulation and ribosome biogenesis, which characterizes proliferating 
cells.[33,34] As shown above, 5 and 6 can exist in, at least, two states. The bright state is associated 
with protonation of the hydroxyl group. Therefore, we hypothesise that the selectivity for cancer 
cells is due to the interaction between the hydroxyl groups of these organotin probes and up-
regulated ribosomal proteins or overexpressed RNA.[35] A previous study of the bioaccumulation 
of organotin compounds gave evidence of binding to sulfhydryl groups on proteins.[36] Therefore, 
a dependence of fluorescence intensity on the HeLa cell cycle machinery could occur via increased 
binding of the organotin compounds to proteins and RNA, due to the overexpression of nearly 
2000 genes in HeLa cells. These genes are related to cell cycle phase and transcription processes.[37] 
Given the promising two-photon cross sections measured for compounds 1-4 in solution (see 
above), we then conducted a preliminary investigation of two of the compounds (1 and 3) for two-
photon imaging inside cells. Two-photon excitation in HeLa cells was accomplished by using 
multiphoton microscopy with excitation at 842 nm, which is close to double the 1P absorption 
maxima. High-resolution images of the cells were generated by raster scanning of the laser spot in 
the xy plane. The images clearly confirm the preferential localization of organotin compounds 1 
and 3 in the cytoplasm that had been observed in the confocal experiments described above. The 
results demonstrate the viability of TPE of complexes 1 and 3 in live cells (Figure 5). The 
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fluorescent bioimaging of other organotin carboxylate complexes have shown promise recently,[38, 
39] so this will be an area that we will explore in the future. Additionally, organotin compounds as 




Figure 5. HeLa cells stained with 5mM of organotin compounds 1 (a) and 3 (b), visualized by 2P 




In summary, we have presented a series of novel fluorescent Schiff base organotin derivatives 
for applications as bioimaging probes; in particular, 2P excitation was demonstrated in solution 
and cells. The compounds with hydroxyl substituents were able to selectively stain one cancer cell 
line (HeLa), which we hypothesise is due to specific interactions with up-regulated products, 
though proof of this will require further study. We plan to extend this approach to probe over 
d)     e)     f)     
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expression in other cancer cell lines and to investigate the use of the Schiff bases as tumor-targeted 
diagnostics.[40] 
 
Supporting Information Summary 
Experimental details; 1H, 13C and 119Sn NMR spectra; high-resolution mass spectra; X-ray structure 
for compound 4; crystallographic data for 4 and 5; and photophysical properties of compounds 1-
6 in ethanol, DMF and DMSO. 
Accession Codes 
CCDC 1827951 and 1827950 for compounds 4 and 5 respectively contain the supplementary 
crystallographic data for this paper. These data can be obtained free of charge via 
www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or by 
contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, 
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were capable of selective accumulation in HeLa cells, allowing differentiation from normal cells 
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staining (HeLa) using two-photon bioimaging, which is promising for biomedicine applications. 
 
 
 
 
 
 
